Delivery Order SPE2DB22D1017-SPE2DB24FF6WJ
Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024, with a completion date of December 13, 2024. The contract has a ceiling value of $13,022.30 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation....
- This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, on April 2, 2024 as a firm fixed price delivery order under an existing indefinite delivery contract (IDC) with a potential value of up to...
- This federal contract award is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor serving federal government agencies. The contract has a ceiling value of $6,802.72 and an ultimate completion date of December 1, 2023. It is a delivery order contract with a firm fixed price pricing...
- This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $4,461.37 and a completion date of January 12, 2024. It is not associated with a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,121.75 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 13, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC enables the DLA to...
- This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $1,356.33 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 15, 2024, with a completion date of March 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
- This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 5, 2024 with a ceiling value of $4,108.77. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 6, 2024. This award is not designated as a...
- The federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,280.62 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with an ultimate completion date of September 13, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
- This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,144.02 and is a firm fixed-price delivery order, with an ultimate completion date of November 25, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is...
- This federal contract award is for the delivery of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product, to the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,643.14, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 18, 2024, with a completion date of July 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation....